The latest at the Foundation | Access to Medicine Foundation

Poor countries desperately need better access to generic medicines

15 February 2023

Here's how we can get better access to sexual and reproductive health to women around the world

02 February 2023

Index finds more pharma companies moving to address access to medicine. Will they now go further?

15 November 2022

First-of-its-kind framework to assess how generics manufacturers expand access to medicine

15 February 2023

Resource Center

Explore our research reports and publications

Featured Key findings

Some companies engaging in R&D for emerging infectious diseases, but pipeline mainly empty

15 November 2022

More access plans and strategies to expand access to more products, but with limited breadth and depth

15 November 2022

Drugmakers that dominate the world's insulin market must scale up access efforts globally

06 October 2022

Implementing strong access strategies across different country income classifications

15 November 2022

GSK in top spot, Johnson & Johnson close second. AstraZeneca leaps up to join the top three. Bayer and Merck climb the Index ranking.

Drug makers must address access to antibiotics to help slow the superbug threat

Impact Summit Europe 2023: Marijn Verhoef to moderate session on healthcare systems and equitable access

Framework to assess, nudge generic drug makers to expand access to products

15 February 2023

Achievements so far

Read more about the Foundation's impact

Closing the gaps in access to diabetes care in low- and middle-income countries

Global oxygen suppliers commit to closing oxygen gaps in low- and middle-income countries